News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TG Therapeutics, Inc. (MHA) Announces Preclinical Poster Presentations For TGR-1202 At American Association for Cancer Research 2014


4/7/2014 8:59:40 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK, April 7, 2014 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq:TGTX) today announced that preclinical data for TGR-1202, the Company's novel PI3k delta inhibitor will be highlighted at the 105th American Association for Cancer Research (AACR) Annual Meeting taking place April 5-9, 2014 in San Diego, California.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   
Lymphoma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES